Edward Feener P.'s most recent trade in KalVista Pharmaceuticals Inc was a trade of 18,789 Common Stock done . Disclosure was reported to the exchange on May 17, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| KalVista Pharmaceuticals Inc | Edward P. Feener | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 18,789 | 80,946 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 11.76 per share. | 17 May 2024 | 8,088 | 72,858 (0%) | 0% | 11.8 | 95,151 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 7,292 | 14,583 | - | - | Performance Stock Units | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 7,292 | 0 | - | - | Performance Stock Units | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 2,431 | 14,583 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 1,774 | 14,190 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 14.04 per share. | 17 Feb 2024 | 19,591 | 62,457 (0%) | 0% | 14.0 | 274,991 | Common Stock |
| KalVista Pharmaceuticals Inc | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2024 | 18,788 | 90,445 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | P. Feener Edward | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 14.11 per share. | 17 Feb 2024 | 8,397 | 82,048 (0%) | 0% | 14.1 | 118,522 | Common Stock |
| KalVista Pharmaceuticals Inc | Feener P. Edward | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2024 | 7,292 | 21,875 | - | - | Performance Stock Units | |
| KalVista Pharmaceuticals Inc | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2024 | 7,292 | 7,292 | - | - | Performance Stock Units | |
| KalVista Pharmaceuticals Inc | Edward Feener P. | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2024 | 2,430 | 17,014 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Feener P. Edward | CHIEF SCIENTIFIC OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2024 | 1,774 | 15,964 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Edward Feener P. | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 14.72 per share. | 17 Feb 2024 | 300 | 62,157 (0%) | 0% | 14.7 | 4,416 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward Feener P. | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 14 Feb 2024 | 28,171 | 71,657 (0%) | 0% | 15.0 | 422,827 | Common Stock |
| KalVista Pharmaceuticals Inc | P. Edward Feener | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2024 | 60,000 | 99,828 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | P. Edward Feener | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2024 | 29,167 | 29,167 | - | - | Performance Stock Units | |
| KalVista Pharmaceuticals Inc | P. Feener Edward | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.03 per share. | 11 Jan 2024 | 22,679 | 39,828 (0%) | 0% | 13.0 | 295,514 | Common Stock |
| KalVista Pharmaceuticals Inc | P. Edward Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.01 per share. | 08 Jan 2024 | 17,221 | 62,607 (0%) | 0% | 13.0 | 224,000 | Common Stock |
| KalVista Pharmaceuticals Inc | P. Feener Edward | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 08 Jan 2024 | 100 | 62,507 (0%) | 0% | 13 | 1,300 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2023 | 11,494 | 78,265 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2023 | 7,291 | 0 | - | - | Performance Stock Unit | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.73 per share. | 17 Aug 2023 | 4,976 | 73,289 (0%) | 0% | 10.7 | 53,386 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2023 | 2,430 | 21,875 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2023 | 1,773 | 19,512 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 2,430 | 26,736 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2022 | 1,774 | 62,906 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2022 | 1,774 | 24,833 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 5.44 per share. | 17 Nov 2022 | 530 | 62,376 (0%) | 0% | 5.4 | 2,883 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2022 | 1,773 | 61,664 (0%) | 0% | - | Common Stock | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2022 | 1,773 | 26,607 | - | - | Restricted Stock Unit | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.96 per share. | 17 Aug 2022 | 532 | 61,132 (0%) | 0% | 15.0 | 7,960 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 28,380 | 28,380 | - | - | Restricted Stock Units | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 18,920 | 18,920 | - | - | Employee Stock Option (Right to Buy) | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.07 per share. | 07 Jan 2022 | 33,800 | 36,034 (0%) | 0% | 7.1 | 238,966 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2022 | 33,800 | 0 | - | - | Employee Stock Option (right to buy) | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2022 | 23,857 | 27,943 | - | - | Employee Stock Option (right to buy) | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.21 per share. | 07 Jan 2022 | 23,857 | 59,891 (0%) | 0% | 8.2 | 195,866 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.52 per share. | 02 Aug 2021 | 6,000 | 8,234 (0%) | 0% | 20.5 | 123,134 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 26.81 per share. | 01 Jun 2021 | 25,786 | 22,448 (0%) | 0% | 26.8 | 691,284 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 26.33 per share. | 01 Jun 2021 | 7,138 | 15,296 (0%) | 0% | 26.3 | 187,973 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 27.05 per share. | 01 Jun 2021 | 1,062 | 14,234 (0%) | 0% | 27.0 | 28,723 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 27.21 per share. | 01 Jun 2021 | 14 | 22,434 (0%) | 0% | 27.2 | 381 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 60,000 | 60,000 | - | - | Employee Stock Option (Right to Buy) | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 24.84 per share. | 03 May 2021 | 6,000 | 48,234 (0%) | 0% | 24.8 | 149,051 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 33.72 per share. | 23 Feb 2021 | 23,441 | 60,505 (0%) | 0% | 33.7 | 790,534 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.97 per share. | 23 Feb 2021 | 5,471 | 55,034 (0%) | 0% | 33.0 | 180,400 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 35.19 per share. | 23 Feb 2021 | 1,288 | 83,946 (0%) | 0% | 35.2 | 45,325 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.73 per share. | 23 Feb 2021 | 800 | 54,234 (0%) | 0% | 31.7 | 25,384 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2021 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2021 | 12,500 | 85,234 (0%) | 0% | 0 | Common Stock | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2020 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 17.14 per share. | 02 Nov 2020 | 6,000 | 72,734 (0%) | 0% | 17.1 | 102,812 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 17.26 per share. | 20 Oct 2020 | 5,600 | 90,041 (0%) | 0% | 17.3 | 96,683 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.75 per share. | 20 Oct 2020 | 5,407 | 78,734 (0%) | 0% | 18.7 | 101,374 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 17.65 per share. | 20 Oct 2020 | 3,600 | 84,141 (0%) | 0% | 17.7 | 63,554 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 20 Oct 2020 | 2,300 | 87,741 (0%) | 0% | 18.0 | 41,407 | Common Stock |
| KalVista Pharmaceuticals Inc | Edward P. Feener | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 16 Oct 2020 | 993 | 95,641 (0%) | 0% | 17 | 16,881 | Common Stock |